The OCAI Group had the pleasure of attending the SEHH Congress in Mallorca! Our team presented an oral communication on their groundbreaking research: "The NLRP1 Inflammasome as a New Component in Sideroblastic Anemia." This presentation highlighted a novel perspective on how the NLRP1 inflammasome could play a crucial role in the pathophysiology of sideroblastic anemia, potentially paving the way for new diagnostic and therapeutic approaches.

Participating in the SEHH Congress allowed OCAI to not only share their findings but also learn from other professionals, gaining insights that will drive future innovations. Inspired and motivated, the OCAI group is excited to tackle new challenges and continue advancing the field of hematology!